ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not ...

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that ...

The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...

People with type 2 diabetes who took low-dose aspirin were less likely to have a heart attack or stroke, University of Pittsburgh researchers reported.

“People with type 2 diabetes and a higher risk of cardiovascular disease who reported taking low-dose aspirin were much less ...

Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group.

Following a slight delay earlier this year—and a world-first green light in the U.K. over the summer—Bayer has clinched an FDA nod to bolster the limited arsenal of nonhormonal treatments for some of ...

The United States Food and Drug Administration (FDA) has approved Bayer’s drug to ease hot flashes in menopausal women, the German company said on Oct 24, a welcome development following the regulator ...

Leading heart experts say the results were "somewhat surprising," and their discovery could warrant a conversation with your ...